XYHD.TV

MRA / MRI Contrast Dye Gadolinium Class Action Suit

Gadolinium based injections used as a contrast agent could cause those with impaired kidney function to develop the serious and potentially fatal disorder, which is associated with the formation of thick and hard skin on the arms and legs, as well as the fibrosis of organs.

If you have received injections of Gadolinium as part of an MRI or for other treatments and have experienced any of the following symptoms you may qualify for one of the Class Action Lawsuits related to Nephrogenic Systemic Fibrosis (NSF), also known as Nephrogenic Fibrosing Dermopathy (NFD):

NFS/NFD is a progressive disorder which is associated with the development of excessive scar tissue and thick, hardened and tight areas of skin which often cover the joints, resulting in severe limitations on movement.  In many cases it renders the victim unable to walk or fully move the joints of their arms, hands, legs and/or feet, and they become dependent on a wheelchair within weeks of the onset.  There is no known cure or effective treatment for Nephrogenic Systemic Fibrosis, and in some cases it can lead to death.

The FDA has indicated that all five of the gadolinium MRI contrast agents which are available could cause the serious problems.  The majority of all reported cases of involve use of Omniscan (gadodiamide).  However, there have been reports of the disorder developing after at least three of the five gadolinium injections.

-- Brandon Wirtz

Tags: fatal disorder;, FDA;, fibrosis;, itching;, MRI;, muscle weakness;, National Science Foundation;, Omniscan;, progressive disorder;, scar;
Filed in: Legal Issues